Biocryst Pharmaceuticals Stock
Biocryst Pharmaceuticals Stock
Biocryst Pharmaceuticals gained 0.860% compared to yesterday.
Biocryst Pharmaceuticals is currently one of the favorites of our community with 20 Buy predictions and no Sell predictions.
With a target price of 15 € there is potential for a 154.76% increase which would mean more than doubling the current price of 5.89 € for Biocryst Pharmaceuticals.
So far the community has only identified positive things for Biocryst Pharmaceuticals stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Biocryst Pharmaceuticals in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
S********** s********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Biocryst Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Biocryst Pharmaceuticals | 0.860% | -13.868% | -9.544% | -16.766% | -10.952% | -37.728% | -17.238% |
| Ardelyx Inc. | 4.460% | 18.588% | 11.880% | 8.474% | 20.399% | 103.685% | 3.500% |
| Evolus Inc | 0.000% | 1.271% | -16.140% | -46.889% | -12.294% | -39.108% | 1.228% |
| Champions Oncology Inc | 4.460% | 2.752% | 8.738% | 17.647% | -3.448% | 40.704% | -37.430% |
Comments
BioCryst Pharmaceuticals (NASDAQ:BCRX) had its price target raised by analysts at HC Wainwright from $30.00 to $32.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BCRX provided by MarketBeat
BioCryst Pharmaceuticals (NASDAQ:BCRX) had its price target lowered by analysts at Needham & Company LLC from $20.00 to $18.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BCRX provided by MarketBeat
BioCryst Pharmaceuticals (NASDAQ:BCRX) had its price target raised by analysts at Cantor Fitzgerald from $24.00 to $26.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for BCRX provided by MarketBeat